Business Context and Reporting Period
The supplied filing is Brooks Automation, Inc.’s unaudited Form 10-Q for the quarter and six months ended March 31, 2017, corresponding to fiscal 2017 second quarter. It does not identify Azenta, Inc.; investors should verify the company and filing-period mapping.
Brooks operated through two reportable segments: Brooks Semiconductor Solutions Group and Brooks Life Science Systems. Its offerings included semiconductor automation and cryogenic solutions, automated and outsourced biological sample-management services, and related storage systems. The company acquired Cool Lab, LLC on November 28, 2016, expanding its cryogenic life-science offerings.
Key Financial Metrics
| Metric | Three months ended March 31, 2017 | Three months ended March 31, 2016 | Six months ended March 31, 2017 | Six months ended March 31, 2016 |
|---|---|---|---|---|
| Revenue | $169.3 million | $135.3 million | $329.3 million | $255.2 million |
| Gross profit | $64.5 million | $46.8 million | $121.5 million | $87.4 million |
| Gross margin | 38.1% | 34.6% | 36.9% | 34.2% |
| Operating income (loss) | $14.8 million | $(6.3) million | $28.0 million | $(14.7) million |
| Net income (loss) | $14.0 million | $(83.9) million | $27.9 million | $(88.6) million |
| Diluted EPS | $0.20 | $(1.22) | $0.40 | $(1.30) |
| Cash flow from operations | Not separately provided | Not separately provided | $43.3 million | $0.4 million |
At March 31, 2017, cash and cash equivalents were $103.9 million and marketable securities were $6.2 million, for total cash and investments of $110.1 million. Accounts receivable were $115.2 million and inventories were $99.1 million. Total assets were $722.2 million and total liabilities were $151.6 million.
The company had no borrowings under its $75.0 million senior secured revolving line of credit and reported approximately $47.8 million of borrowing availability, subject to borrowing-base limitations. It was in compliance with the facility’s covenants. Dividends declared were $0.10 per share per quarter; $13.9 million of dividends were paid during the first six months.
Material Changes Versus the Prior Comparable Period
- Quarterly revenue increased 25%; first-half revenue increased 29%. Semiconductor Solutions revenue rose 24% in the quarter and 26% in the first half, while Life Science Systems revenue rose 31% and 44%, respectively.
- Quarterly gross margin increased 350 basis points to 38.1%; first-half gross margin increased 270 basis points to 36.9%. Management attributed the improvement primarily to operating leverage, higher field-service productivity, lower repair costs, cost reductions, and improved project management.
- Operating results improved from losses to income, reflecting revenue growth, margin expansion, lower research and development expense, and substantially lower restructuring charges.
- Quarterly restructuring charges declined to $0.9 million from $7.3 million; first-half charges declined to $1.8 million from $8.8 million. Restructuring liabilities were $2.0 million at March 31, 2017.
- Net income benefited materially from the prior-year tax comparison. The prior-year periods included a $74.8 million quarterly and $68.6 million first-half adverse impact related primarily to establishing a valuation allowance against U.S. net deferred tax assets.
- First-half operating cash flow increased to $43.3 million from $0.4 million. The improvement reflected the return to profitability and working-capital effects, including higher accounts payable and deferred revenue, partly offset by increases in receivables and inventories.
- The Cool Lab acquisition had a preliminary purchase price of $15.2 million, including $4.8 million in cash and $10.3 million of non-cash consideration. The company recognized a $1.8 million gain on settlement of its BioCision equity-method investment in connection with the transaction.
Outlook, Commentary, Risks, and Unusual Items
No specific revenue, earnings, or margin guidance is provided in the supplied filing. Management stated that available cash, marketable securities, the revolving facility, capital-market access, and operating cash flow were expected to fund working-capital, financing, and capital-expenditure requirements for the next twelve months.
- Management highlighted the cyclical nature of semiconductor capital-equipment demand and the difficulty of forecasting longer-term liquidity needs.
- Approximately $71.7 million of cash was held outside the United States. Repatriation could create tax liabilities, although management expected U.S. net operating loss carryforwards to limit U.S. cash taxes within the next twelve months.
- Fiscal 2017 revenue was expected to be reduced by approximately $8.7 million from patent expirations and $13.0 million from exiting an atmospheric-robot distribution arrangement, compared with fiscal 2016.
- Restructuring actions were expected to produce approximately $14.8 million of reduced annual cash spending when fully implemented. Additional service-operation severance costs of approximately $0.3 million were expected, with the action substantially complete by June 30, 2017.
- One customer represented approximately 10% of quarterly revenue and 11% of first-half revenue. Customer and semiconductor-market concentration therefore remained relevant risks.
- Letters of credit totaled approximately $3.7 million and primarily supported customer advances and performance obligations. None had been called.
- The company disclosed potential rescission rights related to approximately 37,710 improperly registered employee-stock-purchase-plan shares. Maximum estimated payments, including interest, were approximately $0.3 million; possible regulatory penalties were not quantified.
- The filing reported ordinary-course legal proceedings without a currently expected material adverse effect, while acknowledging that outcomes could differ from current assessments.
- Prior-period cost-of-revenue classifications were revised, but management stated that total cost of revenue, gross profit, operating income, net income, earnings per share, balance sheets, and cash flows were unaffected.
Important Facts for Investors to Verify
- Confirm that the filing is intended for Azenta, Inc.; the document names Brooks Automation, Inc., which later became associated with the Azenta corporate identity.
- Separate the underlying operating improvement from unusually favorable prior-year comparisons, particularly the $78.2 million prior-year quarterly tax provision and $74.9 million first-half provision.
- Assess sustainability of the 2017 margin improvement, restructuring savings, semiconductor demand, and the effects of patent expirations and discontinued distribution activities.
- Review the preliminary valuation, goodwill allocation, acquired intangible assets, and integration performance of Cool Lab and the previously acquired BioStorage business.
- Monitor working-capital requirements, including the $99.1 million inventory balance, $115.2 million receivables balance, $115.0 million inventory purchase commitments, and deferred-revenue cash contribution.
- Verify the availability and covenant terms of the revolving facility, the geographic location and repatriation constraints of cash, and the company’s ability to maintain quarterly dividends through a semiconductor downturn.